LifeStance Health Group, Inc. Operating Income
LifeStance Health Group, Inc. (LFST) reported Operating Income of $30.65 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- LifeStance Health Group, Inc. operating income (loss) for the quarter ending 2026-06-30 was $30.65M.
- LifeStance Health Group, Inc. operating income (loss) for the quarter ending 2026-03-31 was $22.28M, a 1289.28% increase year-over-year.
- LifeStance Health Group, Inc. operating income (loss) for the quarter ending 2025-12-31 was $18.08M, a 1607.65% increase year-over-year.
- LifeStance Health Group, Inc. operating income (loss) for the quarter ending 2025-09-30 was $7.41M, a 15665.96% increase year-over-year.
- LifeStance Health Group, Inc. operating income (loss) for fiscal 2025 was $24.15M.
- LifeStance Health Group, Inc. operating income (loss) for fiscal 2024 was -$31.61M.
- LifeStance Health Group, Inc. operating income (loss) for fiscal 2023 was -$189.13M.
- LifeStance Health Group, Inc. operating income (loss) for fiscal 2022 was -$210.17M.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30.65M 10-Q · filed 2026-08-06 | $52.94M 10-Q · filed 2026-08-06 | $71.02M derived: sum of 3 quarters · filed 2026-08-06 | $78.43M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $22.28M 10-Q · filed 2026-05-07 | $40.37M derived: sum of 2 quarters · filed 2026-05-07 | $47.78M derived: sum of 3 quarters · filed 2026-05-07 | $44.83M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $18.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $25.49M derived: sum of 2 quarters · filed 2026-02-25 | $22.54M derived: sum of 3 quarters · filed 2026-08-06 | $24.15M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $7.41M 10-Q · filed 2025-11-06 | $4.46M derived: sum of 2 quarters · filed 2026-08-06 | $6.06M 10-Q · filed 2025-11-06 | $7.12M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$2.95M 10-Q · filed 2026-08-06 | -$1.35M 10-Q · filed 2026-08-06 | -$287.00K derived: sum of 3 quarters · filed 2026-08-06 | -$240.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-07 | $2.66M derived: sum of 2 quarters · filed 2026-05-07 | $2.71M derived: sum of 3 quarters · filed 2026-05-07 | -$13.24M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.11M derived: sum of 2 quarters · filed 2026-02-25 | -$14.84M derived: sum of 3 quarters · filed 2026-02-25 | -$31.61M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $47.00K 10-Q · filed 2025-11-06 | -$15.90M derived: sum of 2 quarters · filed 2025-11-06 | -$32.67M 10-Q · filed 2025-11-06 | -$64.94M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | -$15.95M 10-Q · filed 2025-08-07 | -$32.72M 10-Q · filed 2025-08-07 | -$64.99M derived: sum of 3 quarters · filed 2026-02-25 | -$139.35M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | -$16.77M 10-Q · filed 2025-05-07 | -$49.04M derived: sum of 2 quarters · filed 2026-02-25 | -$123.40M derived: sum of 3 quarters · filed 2026-02-25 | -$171.81M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$32.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$106.63M derived: sum of 2 quarters · filed 2026-02-25 | -$155.04M derived: sum of 3 quarters · filed 2026-02-25 | -$189.13M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | -$74.36M 10-Q · filed 2024-11-07 | -$122.77M derived: sum of 2 quarters · filed 2024-11-07 | -$156.86M 10-Q · filed 2024-11-07 | -$202.88M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$48.41M 10-Q · filed 2024-08-08 | -$82.51M 10-Q · filed 2024-08-08 | -$128.52M derived: sum of 3 quarters · filed 2025-02-27 | -$167.36M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$34.09M 10-Q · filed 2024-05-09 | -$80.11M derived: sum of 2 quarters · filed 2025-02-27 | -$118.94M derived: sum of 3 quarters · filed 2025-02-27 | -$179.42M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$46.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$84.85M derived: sum of 2 quarters · filed 2025-02-27 | -$145.32M derived: sum of 3 quarters · filed 2025-02-27 | -$210.17M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$38.84M 10-Q · filed 2023-11-08 | -$99.31M derived: sum of 2 quarters · filed 2023-11-08 | -$164.16M 10-Q · filed 2023-11-08 | -$277.92M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | -$60.47M 10-Q · filed 2023-08-09 | -$125.32M 10-Q · filed 2023-08-09 | -$239.08M derived: sum of 3 quarters · filed 2024-02-28 | -$363.75M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | -$64.85M 10-Q · filed 2023-05-10 | -$178.61M derived: sum of 2 quarters · filed 2024-02-28 | -$303.28M derived: sum of 3 quarters · filed 2024-02-28 | -$350.32M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | -$113.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$238.43M derived: sum of 2 quarters · filed 2024-02-28 | -$285.47M derived: sum of 3 quarters · filed 2024-02-28 | -$286.35M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$124.67M 10-Q · filed 2022-11-09 | -$171.71M derived: sum of 2 quarters · filed 2022-11-09 | -$172.59M 10-Q · filed 2022-11-09 | -$168.65M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | -$47.05M 10-Q · filed 2022-08-10 | -$47.93M 10-Q · filed 2022-08-10 | -$43.98M derived: sum of 3 quarters · filed 2023-03-09 | -$41.29M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | -$881.00K 10-Q · filed 2022-05-11 | $3.06M derived: sum of 2 quarters · filed 2023-03-09 | $5.76M derived: sum of 3 quarters · filed 2023-03-09 | $5.86M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $3.95M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $6.64M derived: sum of 2 quarters · filed 2023-03-09 | $6.74M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | $2.69M 10-Q · filed 2021-11-10 | $2.79M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $104.00K 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | $3.06M 10-Q · filed 2021-08-12 | $8.70M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $15.24M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |